The spontaneous-death control shows how much marker target cells release without an experimental effector condition, while the maximum-death control represents release after complete target-cell destruction. Comparing the experimental signal with both reference points separates killing attributable to the tested condition from background leakage and establishes the scale needed to quantify immune-mediated cytotoxicity.
These markers reside inside target cells and become measurable in the surrounding medium when the cells are damaged or destroyed. Radioactive chromium provides a released signal that can be compared with control wells, whereas fluorescent intracellular dyes provide a nonradioactive alternative. The measured release therefore serves as an indirect readout of cytotoxic activity.
Changes in Percent Specific Lysis reflect differences in target-cell destruction under defined effector conditions. Greater values can indicate stronger activity after immune-cell activation, antibody-dependent cellular cytotoxicity, or treatment with an experimental cancer therapy. Comparing matched conditions helps connect altered killing with the tested treatment or cell-to-cell interaction rather than with baseline target-cell death.
Researchers measure marker release from target cells exposed to the experimental effector condition, untreated target cells representing spontaneous release, and targets subjected to complete lysis for the maximum signal. These measurements provide the experimental, background, and upper-reference values required to calculate the proportion of target-cell destruction specifically associated with the tested condition.
This metric is useful when investigators need to evaluate cytotoxic function across immune or therapeutic conditions. Applications include measuring natural killer cell activity, assessing cytotoxic T-cell responses, examining antibody-dependent cellular cytotoxicity, and testing experimental cancer therapies. Its comparative format allows researchers to examine how activation or treatment changes target-cell killing.
Values should be interpreted by comparing conditions that use the same target-cell and control framework. A higher result indicates more target-cell destruction attributable to the tested effector or treatment relative to spontaneous and maximum release references. Such comparisons can reveal whether activation, therapy, or altered cell interaction increases or decreases cytotoxic activity.